Obesity & Liver Disorders (NAFLD/NASH)
This track focuses on obesity’s role in liver diseases, particularly fatty liver disorders. Presenters will discuss the pathogenesis of NAFLD and NASH, diagnostic imaging, and biomarker advances. Attendees will learn about lifestyle, pharmacologic, and surgical interventions that improve liver health. The session highlights emerging drug therapies under investigation. Multidisciplinary approaches involving hepatologists, dietitians, and metabolic specialists are emphasized. Clinical case discussions will enhance learning.